For the Culture By The Culture. ISSN: 3064-9331.
France keeps extending medical cannabis access while politically resisting broader legalization. Pot Culture Magazine examines the country’s cautious framework, frozen patient access, regulatory delays, and the growing contradiction between public rhetoric and the reality of cannabis reform already unfolding inside France.
Cannabis media is undergoing a predictable institutional decay. The movement’s original architects have transformed from revolutionary contributors into defensive gatekeepers, protecting their legacy rather than fostering future growth. This manifesto examines the four archetypes of decay: the Gatekeeper, the Mercenary, the Scavenger, and the Shill, that currently stifle the industry’s independent voice and threaten the future of cannabis culture.
4/20 has been hollowed out by branding, corporate silence, and a culture that forgot its own history. While the industry sells holiday merch, Singapore executed a man for cannabis. The movement that once fought for autonomy now treats the plant like a commodity. This piece examines the cost of that betrayal and the culture left behind.
Ed Rosenthal recounts how the magazine was born not from psychedelic myth but from hard numbers. Rolling paper import data, underground press experience, and market logic revealed a massive hidden cannabis audience. His account challenges the romantic origin story and offers a rare firsthand look at the early mechanics behind one of cannabis culture’s most influential publications.
For decades, politicians have claimed marijuana is a gateway to heroin and harder drugs. Federal youth surveys, NSDUH data, and NIDA’s own language tell a different story. Cannabis use is widespread, hard drug use remains rare, and most users do not progress. The data dismantles one of prohibition’s most durable fear narratives.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.